Article

Rudolph Navari on Preventing CINV With Olanzapine

Author(s):

Rudolph Navari, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.

Rudolph Navari, director, Cancer Care Program in Central and South America, World Health Organization, professor of medicine, Indiana University School of Medicine-South Bend, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
CURE sat down with Dr. Tanja A. Gruber of Stanford Medicine Children’s Health to discuss clinical trials in infant leukemia.
Image of melanoma
image of Kelsey Martin